Clinical Trials at Opelousas General
During the past decade, Opelousas General conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Opelousas General"
#1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Opelousas General
According to Clinical.Site data, the most researched conditions in "Opelousas General" are
"Acute DVT of Lower Extremity" (1 trials), "Cardiovascular Disease." (1 trials), "Chronic DVT of Lower Extremity" (1 trials), "DVT" (1 trials) and "Deep Vein Thrombosis Leg" (1 trials). Many other conditions were trialed in "Opelousas General" in a lesser frequency.
Clinical Trials Intervention Types at Opelousas General
Most popular intervention types in "Opelousas General" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anticoagulation Agents" (1 trials), "Arstasis Access System (AXERA)" (1 trials), "ClotTriever" (1 trials), "FlowTriever System" (1 trials) and "SUPERA® Nitinol Stent System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Opelousas General
The vast majority of trials in "Opelousas General" are
4 trials for "All" genders.
Clinical Trials Status at Opelousas General
Currently, there are NaN active trials in "Opelousas General".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in Opelousas General,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Opelousas General, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".